Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana.
Retin Cases Brief Rep. 2024 Mar 1;18(2):218-220. doi: 10.1097/ICB.0000000000001346.
To report the development of bilateral cystoid macular edema after bimatoprost implant (Durysta) injections in both eyes to treat primary open-angle glaucoma.
Case report.
A 93-year-old woman with a history of primary open-angle glaucoma received bimatoprost implant (Durysta) injections in both eyes 4 weeks apart. The patient subsequently developed progressively decreased visual acuity in both eyes because of bilateral cystoid macular edema, which improved with topical corticosteroid therapy.
Bimatoprost implant (Durysta) can cause cystoid macular edema in susceptible individuals. Patients who received the implant should be assessed for the presence of cystoid macular edema after any decline in visual acuity, particularly in high-risk patients.
报告两例因原发性开角型青光眼接受贝美前列素植入剂（卢美根）治疗而发生双侧囊样黄斑水肿的病例。
病例报告。
一名 93 岁女性因原发性开角型青光眼，双眼 4 周内分别接受贝美前列素植入剂（卢美根）注射治疗。随后，该患者因双侧囊样黄斑水肿导致双眼视力逐渐下降，局部皮质类固醇治疗后有所改善。
贝美前列素植入剂（卢美根）可能使易感个体发生囊样黄斑水肿。任何视力下降，特别是高危患者，都应评估接受植入治疗的患者是否存在囊样黄斑水肿。
